If anybody needs reagents, we do have nice Andesvirus specific mAbs that we are happy to share (here: https://t.co/OVxFQBQEtK) and unpublished broadly neutralizing hantavirus mAbs. Just shoot me an email.
New paper out from the lab on our recombinant NA vaccine candidate. Great collaboration with University of Montana and Inimmune. https://t.co/3hrbp6ZIMz
1) Episode 0 of my new podcast viroLOGICAL is online. This first episode is a little longer and gives a general overview of viruses and viral diseases.
➡️ Spotify:
https://t.co/ijZFk6dPsl
➡️ Apple Podcasts:
https://t.co/L2q2Ntci2Z
➡️ Podigee:
https://t.co/LdFHt6aJ6j
An H5N1 clade 2.3.4.4b virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteins
https://t.co/AiMdend4p4
We still don’t understand how T cells control tuberculosis. Our new paper shows that Mtb-specific T cells in NHP and human lung granulomas make many interesting effector molecules upon TCR stimulation. There’s a whole lot more to T cells in TB than IFNγ!
https://t.co/30hEKjFnnu
New @PNASNews
"This work represents the most extensive study to
date regarding the effect of tattoo ink on the immune response and raises serious health concerns associated with the tattooing" including altering the response to vaccination
https://t.co/flxZjpN3LI
A groundbreaking paper by @younis_sh1 et al. @stanfordimmuno provides an answer to the long-standing question about how EBV infections are linked to lupus. A short thread to explain the key findings. (1/)
https://t.co/dUpz19IjEv